Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-030250

Options or other derivatives

  • Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Von Seggern Christopher · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X05/ownership.xml…